Prognostic significance of co-expression of RON and MET receptors in node-negative breast cancer patients.
about
An expression signature of syndecan-1 (CD138), E-cadherin and c-met is associated with factors of angiogenesis and lymphangiogenesis in ductal breast carcinoma in situLRIG1 is a novel negative regulator of the Met receptor and opposes Met and Her2 synergyUnderstanding and Targeting MET Signaling in Solid Tumors - Are We There Yet?Pathogenesis of RON receptor tyrosine kinase in cancer cells: activation mechanism, functional crosstalk, and signaling addictionRon receptor tyrosine kinase signaling as a therapeutic targetExpression of the RON receptor tyrosine kinase and its association with gastric carcinoma versus normal gastric tissues.The RON receptor tyrosine kinase in pancreatic cancer pathogenesis and its potential implications for future targeted therapiesRON and c-Met facilitate metastasis through the ERK signaling pathway in prostate cancer cellsThe Ron receptor tyrosine kinase activates c-Abl to promote cell proliferation through tyrosine phosphorylation of PCNA in breast cancerRon-receptor tyrosine kinase in tumorigenesis and metastasisMet-related receptor tyrosine kinase Ron in tumor growth and metastasis.Ron receptor tyrosine kinase activation confers resistance to tamoxifen in breast cancer cell linesDeletion or insertion in the first immunoglobulin-plexin-transcription (IPT) domain differentially regulates expression and tumorigenic activities of RON receptor Tyrosine Kinase.Significance of c-MET overexpression in cytotoxic anticancer drug-resistant small-cell lung cancer cellsβ-Catenin is required for Ron receptor-induced mammary tumorigenesisThe monoclonal antibody Zt/f2 targeting RON receptor tyrosine kinase as potential therapeutics against tumor growth-mediated by colon cancer cells.RON (MST1R) is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma.Novel function of transcription factor Nrf2 as an inhibitor of RON tyrosine kinase receptor-mediated cancer cell invasion.The macrophage-stimulating protein pathway promotes metastasis in a mouse model for breast cancer and predicts poor prognosis in humansVitamin D3-dependent VDR signaling delays ron-mediated breast tumorigenesis through suppression of β-catenin activity.HGFL supports mammary tumorigenesis by enhancing tumor cell intrinsic survival and influencing macrophage and T-cell responses.Oncogenesis of RON receptor tyrosine kinase: a molecular target for malignant epithelial cancers.c-Met overexpression in inflammatory breast carcinomas: automated quantification on tissue microarraysBiological evaluation of antibody-maytansinoid conjugates as a strategy of RON targeted drug delivery for treatment of non-small cell lung cancerSignificance of the entire C-terminus in biological activities mediated by the RON receptor tyrosine kinase and its oncogenic variant RON160Ron tyrosine kinase receptor synergises with EGFR to confer adverse features in head and neck squamous cell carcinoma.The RON receptor tyrosine kinase promotes MSP-independent cell spreading and survival in breast epithelial cells.Dietary chemopreventative benzyl isothiocyanate inhibits breast cancer stem cells in vitro and in vivo.The proteome signature of the inflammatory breast cancer plasma membrane identifies novel molecular markers of diseaseMet interacts with EGFR and Ron in canine osteosarcomaSelection criteria for c-Met-targeted therapies: emerging evidence for biomarkers.Recepteur d'origine nantais (RON), more than a kinase: Role in castrate-resistant prostate cancer.α-Ketobenzothiazole Serine Protease Inhibitors of Aberrant HGF/c-MET and MSP/RON Kinase Pathway Signaling in Cancer.Strategies of targeting the extracellular domain of RON tyrosine kinase receptor for cancer therapy and drug delivery.Phase 1 study of narnatumab, an anti-RON receptor monoclonal antibody, in patients with advanced solid tumors.The role of HER2, EGFR, and other receptor tyrosine kinases in breast cancer.Prevention of BMS-777607-induced polyploidy/senescence by mTOR inhibitor AZD8055 sensitizes breast cancer cells to cytotoxic chemotherapeutics.Macrophage stimulating protein promotes liver metastases of small cell lung cancer cells by affecting the organ microenvironment.Expression of the receptor tyrosine kinase recepteur d'origine nantais and its association with tumor progression in hypopharyngeal cancer.Prognostic significance of phosphorylated RON in esophageal squamous cell carcinoma.
P2860
Q21195234-28853F48-2905-4591-96D5-4F9FCD573A07Q24681561-66DCDFA2-AAD8-4D43-AFEA-E764292C54F4Q26748581-27884DEF-CB98-469A-AEE6-B8811B71EEEFQ26864275-763BA34C-B90D-4B32-B68C-7539E5D15D84Q27003295-454F6E1C-691D-4C53-8283-E8CBECDAA5FDQ33387952-7BE3C6BA-669C-4D74-A6FC-37080CE94A96Q33563635-A43590FD-F842-48E7-80A2-43287EC43C1EQ33721142-4527DA6F-40AC-4755-9E0A-2BCE2B586FDDQ33783151-2D86E487-DDF3-4C01-B944-DC153264E9C6Q33850098-AAE8797F-96E1-457C-B153-9BC8283D06DBQ33916081-A868B9D5-3F4B-498D-BEF3-F695AA3307D4Q34041328-3A3E023F-FA2D-4223-A1A1-71D0F63E2EF2Q34405019-0ECC7451-3712-4F5E-81F6-962F17719B65Q35051630-30D98A91-15A0-48B1-B351-5EF236C3486BQ35100064-EDD887AD-D586-4D70-BFA2-AF9816E88D2EQ35124768-5DCB2174-CF38-452E-A08C-96560B42B8AFQ35146597-C94E5F9E-9CFD-41B3-85D0-D7A918FAE29BQ35213365-161B551E-1F8C-45CD-9001-DD6D5FE475AFQ35758261-8354E7AE-8845-481E-B05F-167BCD828EA2Q36140785-91E5A9CB-5DF1-45C0-BC88-77B59CF67582Q36232073-6A73A8B4-BD68-4F42-89A0-7FB1691C5D5BQ36488410-4717EE73-A471-4EB2-8684-7CCB780BBB87Q36609706-7F7FDC47-9895-43AD-B203-5BD81C5246B5Q36824455-037630F3-A8B2-48C0-9653-1BEC2806A301Q36975164-EBF066DE-0B3E-4AE4-B25A-9F8CF40C5AC9Q37040636-17960BE8-2743-460D-823A-A3036227BEA1Q37066428-3C624216-AFDA-4173-8F95-981E6789C257Q37079634-1A043B08-351F-4405-BA3C-AD3E1D6389AEQ37215538-842F0D59-E5BE-4B2F-ADAB-2AA447B730EDQ37672081-49326E8D-0D90-4196-872B-1F2AAB7A86AEQ37730020-73A5D226-B207-40F8-9A5F-89AD51621429Q38543678-D1B55BA1-53FB-491D-A864-90039A64DD5BQ38793227-500661C3-B5CB-4645-B283-DF174767EEB6Q38922319-05FCCD87-D459-4DE1-A5AA-1E6638AAF104Q38978586-20B8D5BE-1E5E-4B56-9B59-2D864454967DQ39028181-BEEBF1F6-528B-43A2-B243-231D4060A402Q39032726-F3A60045-B092-4F06-8E6E-3DDEAC6A2E90Q39271429-F9134F2D-5997-4F41-B9C2-3ADBB6495736Q39298765-39436BA9-FDD4-4F4B-9FCD-ED6EFE664DCFQ39442425-71480762-DD16-43EC-BE9C-0E5ADF8911EC
P2860
Prognostic significance of co-expression of RON and MET receptors in node-negative breast cancer patients.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Prognostic significance of co- ...... gative breast cancer patients.
@en
type
label
Prognostic significance of co- ...... gative breast cancer patients.
@en
prefLabel
Prognostic significance of co- ...... gative breast cancer patients.
@en
P2093
P1476
Prognostic significance of co- ...... egative breast cancer patients
@en
P2093
Helen H W Chen
Nan-Haw Chow
Pin-Wen Lin
Wen-Ying Lee
P304
P356
10.1158/1078-0432.CCR-04-1761
P407
P577
2005-03-01T00:00:00Z